Astrazeneca (AZN) Net Cash Flow (2009 - 2026)
Astrazeneca's Net Cash Flow was $1.62 billion in Q2 2026, down 58.9% from $3.94 billion a year earlier and down 60.5% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Net Cash Flow (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Net Cash Flow was $17.55 billion through Jun 30, 2026, down 7.5% year-over-year; for FY2025, it came in at $19.7 billion, up 66.6% from FY2024.
- Net Cash Flow shows a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
- In earlier years, Net Cash Flow was $11.83 billion in FY2024 (-26.1%), $16.01 billion in FY2023 (-1.0%), $16.17 billion in FY2022 and -$7.73 billion in FY2021.
- The Q2 2026 figure marks the lowest quarterly Net Cash Flow since Q2 2024.
- Compared with a year earlier, Net Cash Flow was higher in four of the last six quarters, with growth averaging 106.1%.
- The best year-over-year quarter for Net Cash Flow over five years was Q1 2025 (growth of 522.1%); the worst was Q1 2024 (a decline of 78.5%).
- Per Business Quant data, AZN's Net Cash Flow in the three quarters before Q2 2026 was $4.1 billion (Q1 2026), $4.47 billion (Q4 2025) and $7.36 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.27 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -722.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 652.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Bn |
| Mar 31, 2026 | 4.10 Bn |
| Dec 31, 2025 | 4.47 Bn |
| Sep 30, 2025 | 7.36 Bn |
| Jun 30, 2025 | 3.94 Bn |
| Mar 31, 2025 | 5.71 Bn |
| Dec 31, 2024 | 4.46 Bn |
| Sep 30, 2024 | 4.87 Bn |
| Jun 30, 2024 | 1.58 Bn |
| Mar 31, 2024 | 917.00 Mn |
| Jun 30, 2023 | 3.46 Bn |
| Mar 31, 2023 | 4.26 Bn |
| Jun 30, 2022 | 1.87 Bn |
| Mar 31, 2022 | 6.55 Bn |
| Dec 31, 2021 | -4.35 Bn |
| Sep 30, 2021 | -16.96 Bn |
| Jun 30, 2021 | 1.99 Bn |
| Mar 31, 2021 | 5.50 Bn |
| Dec 31, 2020 | 4.43 Bn |
| Sep 30, 2020 | 3.09 Bn |
API Access
Astrazeneca Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();